Moderna vs. BioNTech: Why Only 1 Is a Buy Heading Into 2027
Key PointsBoth companies are working to move beyond their coronavirus vaccine windfalls.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.